幽门螺杆菌根除失败后阿莫西林耐药性增强。
Enhancement of amoxicillin resistance after unsuccessful Helicobacter pylori eradication.
机构信息
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
出版信息
Antimicrob Agents Chemother. 2011 Jun;55(6):3012-4. doi: 10.1128/AAC.00188-11. Epub 2011 Apr 12.
Abstract
A high rate of resistance (49.5 to 72.7%) to amoxicillin (AMX) was observed in Helicobacter pylori after two or three unsuccessful eradication attempts. Unsuccessful eradication regimens significantly increase resistance to not only clarithromycin (CLR) and metronidazole (MNZ) but also AMX.
摘要
在两次或三次根除尝试失败后，观察到幽门螺杆菌对阿莫西林（AMX）的耐药率很高（49.5 至 72.7%）。不成功的根除方案不仅显著增加了克拉霉素（CLR）和甲硝唑（MNZ）的耐药性，也增加了 AMX 的耐药性。
相似文献
1
Enhancement of amoxicillin resistance after unsuccessful Helicobacter pylori eradication.
Antimicrob Agents Chemother. 2011 Jun;55(6):3012-4. doi: 10.1128/AAC.00188-11. Epub 2011 Apr 12.
2
Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful?
J Pediatr Gastroenterol Nutr. 2005 May;40(5):571-4. doi: 10.1097/01.mpg.0000155567.71902.75.
3
Clarithromycin Versus Metronidazole as First-line Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized Controlled Study in Japan.
J Clin Gastroenterol. 2015 Jul;49(6):468-71. doi: 10.1097/MCG.0000000000000165.
4
10-Year Trends in Helicobacter pylori Eradication Rates by Sitafloxacin-Based Third-Line Rescue Therapy.
Digestion. 2020;101(5):644-650. doi: 10.1159/000501610. Epub 2019 Aug 6.
5
Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for infection.
Gut Microbes. 2020 Sep 2;11(5):1314-1323. doi: 10.1080/19490976.2020.1754118. Epub 2020 May 2.
6
High Helicobacter pylori resistance to metronidazole and clarithromycin in Brazilian children and adolescents.
J Pediatr Gastroenterol Nutr. 2013 Jun;56(6):645-8. doi: 10.1097/MPG.0b013e31828b3669.
7
Antimicrobial-resistant Helicobacter pylori in Japan: Report of nationwide surveillance for 2018-2020.
Helicobacter. 2024 Jan-Feb;29(1):e13028. doi: 10.1111/hel.13028. Epub 2023 Oct 12.
8
Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.
Helicobacter. 2019 Feb;24(1):e12557. doi: 10.1111/hel.12557. Epub 2018 Nov 20.
9
Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
Helicobacter. 2013 Dec;18(6):459-67. doi: 10.1111/hel.12062. Epub 2013 May 29.
10
A new eradication resistance index as a predictor of metronidazole-containing second-line treatment of Helicobacter pylori.
Digestion. 2007;76(3-4):215-20. doi: 10.1159/000112649. Epub 2007 Dec 21.
引用本文的文献
1
Evidence of Helicobacter pylori heterogeneity in human stomachs by susceptibility testing and characterization of mutations in drug-resistant isolates.
Sci Rep. 2024 May 27;14(1):12066. doi: 10.1038/s41598-024-62200-1.
2
Molecular Mechanisms of Antibiotic Resistance and Novel Treatment Strategies for Infections.
Trop Med Infect Dis. 2023 Mar 11;8(3):163. doi: 10.3390/tropicalmed8030163.
3
Clinical Implications of Antibiotic Resistance in Italy: A Review of the Literature.
Antibiotics (Basel). 2022 Oct 21;11(10):1452. doi: 10.3390/antibiotics11101452.
4
Efficacy and safety of low-dose rifabutin-based 7-day triple therapy as a third- or later-line Helicobacter pylori eradication regimen.
Helicobacter. 2022 Aug;27(4):e12900. doi: 10.1111/hel.12900. Epub 2022 May 29.
5
Interplay between Amoxicillin Resistance and Osmotic Stress in Helicobacter pylori.
J Bacteriol. 2022 May 17;204(5):e0004522. doi: 10.1128/jb.00045-22. Epub 2022 Apr 7.
6
Sitafloxacin for Third-Line Eradication: A Systematic Review.
J Clin Med. 2021 Jun 20;10(12):2722. doi: 10.3390/jcm10122722.
7
Genetic and Transcriptomic Variations for Amoxicillin Resistance in under Cryopreservation.
Pathogens. 2021 May 30;10(6):676. doi: 10.3390/pathogens10060676.
8
Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications.
Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):613-629. doi: 10.1038/s41575-021-00449-x. Epub 2021 May 17.
9
Whole-Genome Sequencing and Comparative Genomics of Three Strains Isolated from the Stomach of a Patient with Adenocarcinoma.
Pathogens. 2021 Mar 12;10(3):331. doi: 10.3390/pathogens10030331.
10
Eradication According to Sequencing-Based 23S Ribosomal RNA Point Mutation Associated with Clarithromycin Resistance.
J Clin Med. 2019 Dec 25;9(1):54. doi: 10.3390/jcm9010054.
本文引用的文献
1
Enhanced bacterial efflux system is the first step to the development of metronidazole resistance in Helicobacter pylori.
Biochem Biophys Res Commun. 2011 Jan 14;404(2):656-60. doi: 10.1016/j.bbrc.2010.12.034. Epub 2010 Dec 11.
2
Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori.
J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S75-9. doi: 10.1111/j.1440-1746.2009.06220.x.
3
Helicobacter pylori eradication therapy.
Future Microbiol. 2010 Apr;5(4):639-48. doi: 10.2217/fmb.10.25.
4
Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication.
J Clin Biochem Nutr. 2009 Mar;44(2):119-24. doi: 10.3164/jcbn.08-220R. Epub 2009 Feb 28.
5
Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation.
Antimicrob Agents Chemother. 2009 Apr;53(4):1720-1. doi: 10.1128/AAC.00049-09. Epub 2009 Feb 2.
6
Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication.
J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S167-70. doi: 10.1111/j.1440-1746.2008.05407.x.
7
Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori.
J Antimicrob Chemother. 2008 May;61(5):995-8. doi: 10.1093/jac/dkn051. Epub 2008 Feb 14.
8
A new eradication resistance index as a predictor of metronidazole-containing second-line treatment of Helicobacter pylori.
Digestion. 2007;76(3-4):215-20. doi: 10.1159/000112649. Epub 2007 Dec 21.
9
Rapid detection of point mutations conferring resistance to fluoroquinolone in gyrA of Helicobacter pylori by allele-specific PCR.
J Clin Microbiol. 2007 Feb;45(2):303-5. doi: 10.1128/JCM.01997-06. Epub 2006 Nov 22.
10
Gatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan.
Antimicrob Agents Chemother. 2006 Apr;50(4):1538-40. doi: 10.1128/AAC.50.4.1538-1540.2006.
Zotero 插件